I’m just hoping that management won’t capital raise if the FDA comes back with two trials. That plus the fact that a whole slab of shares come out of escrow in the next month worries me.
I think the FDA hasn’t realised the anger they will invoke from American patients if European patients get Presendin several years before them.
Young, female patients suffering from terrible headaches and losing their vision, whilst the EU has a safe and effective drug because they backed an orphan drug developer. I would think several patients will self fund it without reimbursement...
Invex needs to do a better job of harnessing their patient voices to start the advocating to the FDA if the suggested trials don’t go their way.
- Forums
- ASX - By Stock
- Ann: Invex Granted Type C Meeting with FDA
I’m just hoping that management won’t capital raise if the FDA...
-
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28320 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 22452 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28320 | 0.070 |
1 | 84879 | 0.067 |
1 | 100000 | 0.066 |
1 | 100000 | 0.065 |
2 | 166666 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 22452 | 2 |
0.080 | 5000 | 1 |
0.085 | 8805 | 1 |
0.090 | 126146 | 1 |
0.095 | 100000 | 1 |
Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable